STUDIES OF PLATELET FACTOR 4 AND B-THROMBOGLOBULIN
血小板因子 4 和 B-血栓球蛋白的研究
基本信息
- 批准号:3353066
- 负责人:
- 金额:$ 12.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-12-01 至 1991-11-30
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coli affinity chromatography binding proteins chemotaxis chromosome complement genetic library genetic manipulation membrane proteins molecular cloning nucleic acid probes nucleic acid sequence platelet factor 4 protein engineering protein sequence recombinant DNA suppressor T lymphocyte thrombin tissue /cell culture
项目摘要
The long-term objective of this grant is to further the
understanding of the genomic organization, biological roles and
structural/functional relationships of platelet factor 4 (PF4) and
Beta-thromboglobulin (Beta TG) in humans using recombinant
DNA technologies to clone, sequence and express these genes in
bacteria. PF4 and Beta TG are members of a family of related
proteins (which also includes gamma IP-10, a protein synthesized
by many cell lines following gamma-interferon stimulation) that
appear to have significant roles in the inter-related processes of
coagulation, chemotaxis, immunoregulation and tissue repair. A
better understanding of the biological function of these two
proteins and their structural/functional relationships may provide
new insights into such pathologic states as thrombosis in
atherosclerotic vessels during myocardial infarcts and
cerebrovascular thromboembolisms. There are 2 specific aims to
the proposed research: 1) Further characterization of PF4 and
Beta TG cDNA and genomic DNA in humans and other mammalian
and avian species using a PF4 cDNA probe already isolated and a
Beta TG cDNA probe that I propose to isolate in a similar fashion.
These studies should result in new information on protein
precursors, their intracellular processing, and the evolutionary
relationship between these proteins, as well as provide amino acid
sequence data for deciding what modifications of these proteins
may yield new biological information. 2) Studies on the
relationship between protein structure and function using site-
directed amino acid replacement. The natural proteins and
precursor and induced mutations will be synthesized in E.coli,
purified and used in biologic assays. Modification of PF4 will
include a) alteration of the functionally important COOH-
terminus of human PF4 to resemble Beta TG in order to study the
relationships between these differences and the different biologic
functions of the two proteins, and b) disruption of the secondary
organization of PF4 by modification of one or more of the four
cysteine residues that occupy homologous positions in PF4, Beta
TG and gamma IP-10. Biologic functions to be tested include
heparin affinity, platelet binding and activation,
immunoregulatory activity, and chemotaxis for monocytes and
fibroblasts.
这笔赠款的长期目标是促进
了解基因组组织,生物学作用和
血小板因子4(PF 4)的结构/功能关系,
使用重组人β-血小板球蛋白(β TG)
DNA技术克隆、测序和表达这些基因,
细菌 PF 4和β TG是一个家族的成员,
蛋白质(还包括γ IP-10,一种合成的蛋白质
通过γ-干扰素刺激后的许多细胞系),
似乎在相互关联的过程中发挥着重要作用,
凝血、趋化性、免疫调节和组织修复。 一
更好地了解这两种基因的生物学功能
蛋白质及其结构/功能关系可以提供
对血栓形成等病理状态的新认识,
心肌梗死期间的动脉粥样硬化血管,
脑血管血栓栓塞 有两个具体目标,
建议的研究:1)进一步表征PF 4和
人和其他哺乳动物中的β TG cDNA和基因组DNA
和鸟类物种使用PF 4 cDNA探针已经分离和
β TG cDNA探针,我建议以类似的方式分离。
这些研究应该会带来关于蛋白质的新信息。
前体,它们的细胞内加工,以及进化
这些蛋白质之间的关系,以及提供氨基酸
序列数据来决定这些蛋白质的哪些修饰
可能会产生新的生物信息。 2)的研究
蛋白质结构与功能的关系
定向氨基酸置换。 天然蛋白质和
前体和诱导突变将在大肠杆菌中合成,
纯化并用于生物测定。 PF 4的修改将
包括a)改变功能上重要的COOH-
人PF 4末端类似于β TG,以研究
这些差异与不同生物学特性之间的关系
B)破坏所述两种蛋白质的次级功能,
PF 4的组织通过修改一个或多个四个
占据PF 4、β中同源位置的半胱氨酸残基
TG和gamma IP-10。 待检测的生物学功能包括
肝素亲和力、血小板结合和活化,
免疫调节活性和单核细胞的趋化性,
成纤维细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mortimer Poncz其他文献
Mortimer Poncz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mortimer Poncz', 18)}}的其他基金
Mechanistic and Therapeutic Studies using a Xenotransplanted RUNX1-Haploinsufficient Murine Model
使用异种移植 RUNX1-单倍体不足小鼠模型进行机制和治疗研究
- 批准号:
10721954 - 财政年份:2023
- 资助金额:
$ 12.25万 - 项目类别:
Platelet Factor 4 and heparins in NETosis and Sepsis
血小板因子 4 和肝素在 NETosis 和脓毒症中的作用
- 批准号:
10161824 - 财政年份:2020
- 资助金额:
$ 12.25万 - 项目类别:
Platelet Factor 4 and heparins in NETosis and Sepsis
血小板因子 4 和肝素在 NETosis 和脓毒症中的作用
- 批准号:
10656307 - 财政年份:2020
- 资助金额:
$ 12.25万 - 项目类别:
Platelet Factor 4 and heparins in NETosis and Sepsis
血小板因子 4 和肝素在 NETosis 和脓毒症中的作用
- 批准号:
10434812 - 财政年份:2020
- 资助金额:
$ 12.25万 - 项目类别:
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets
新的机制见解
- 批准号:
10616531 - 财政年份:2020
- 资助金额:
$ 12.25万 - 项目类别:
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets
新的机制见解
- 批准号:
10404491 - 财政年份:2020
- 资助金额:
$ 12.25万 - 项目类别:
New Mechanistic Insights & Therapeutic Applications of Megakaryocytes/Platelets
新的机制见解
- 批准号:
9888868 - 财政年份:2020
- 资助金额:
$ 12.25万 - 项目类别:
Biology and Application of Platelet-Delivered Factor VIII
血小板递送因子VIII的生物学和应用
- 批准号:
9264016 - 财政年份:2016
- 资助金额:
$ 12.25万 - 项目类别:
Biology and Application of Platelet-Delivered Factor VIII
血小板递送因子VIII的生物学和应用
- 批准号:
9126648 - 财政年份:2016
- 资助金额:
$ 12.25万 - 项目类别:
Administrative Core for Gene Therapy of Hemophilia
血友病基因治疗的行政核心
- 批准号:
8691970 - 财政年份:2014
- 资助金额:
$ 12.25万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 12.25万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 12.25万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 12.25万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 12.25万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 12.25万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 12.25万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 12.25万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 12.25万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 12.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 12.25万 - 项目类别:
Collaborative Research and Development Grants